The Relationship between 10 Years Risk of Cardiovascular Disease and Schizophrenia Symptoms: Preliminary Results

Esin Evren Kilicaslan1, Merve Karakilic1, Almila Erol1

  • 1Department of Psychiatry, Atatürk Education and Training Hospital, Izmir Katip Celebi University, Izmir, Turkey.

Psychiatry Investigation
|December 6, 2019
PubMed

Insights

Patients with schizophrenia have a higher risk of cardiovascular disease, linked to illness duration and antipsychotic use. This study investigated the connection between heart disease risk and schizophrenia symptoms.

Area of Science:

  • Cardiology
  • Psychiatry
  • Public Health

Background:

  • Schizophrenia patients face elevated cardiovascular disease (CVD) risk compared to the general population.
  • Factors contributing to this risk include antipsychotic medications, genetic predispositions, and lifestyle choices.
  • Understanding the interplay between schizophrenia and CVD is crucial for patient management.

Purpose of the Study:

  • To investigate the relationship between cardiovascular disease risk and schizophrenia symptomatology.
  • To assess 10-year cardiovascular risk using the Framingham Risk Score (FRS) in schizophrenia patients and healthy controls.

Main Methods:

  • The Framingham Risk Score (FRS) was calculated for 103 schizophrenia patients and 39 controls.
  • Data collected included sociodemographics, illness onset/duration, hospitalizations, and antipsychotic use.
  • Symptom severity was assessed using the Scale for the Assessment of Negative Symptoms (SANS), Scale for the Assessment of Positive Symptoms (SAPS), and Calgary Depression Scale for Schizophrenia (CDSS).

Main Results:

  • Schizophrenia patients exhibited a significantly higher 10-year cardiovascular risk (5.16%) than controls (3.02%).
  • FRS scores correlated significantly with age, number of hospitalizations, and illness duration.
  • Patients on multiple antipsychotics showed higher FRS scores and lower high-density lipoprotein (HDL) levels.

Conclusions:

  • Cardiovascular disease risk in schizophrenia is associated with illness duration and overall severity.
  • Antipsychotic medication use, particularly multiple agents, plays a role in elevated cardiovascular risk.
  • Further research is needed to mitigate CVD risk in schizophrenia patients.
Abstract

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.7K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
344
Schizophrenia01:17

Schizophrenia

Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
638
Negative and Cognitive Symptoms of Schizophrenia01:30

Negative and Cognitive Symptoms of Schizophrenia

Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
369
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
438
Psychological and Sociocultural Causes of Schizophrenia01:29

Psychological and Sociocultural Causes of Schizophrenia

Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
420